These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6159662)

  • 1. Effect of citalopram (Lu 10-171) on tranylcypromine and tryptophan-induced wet-dog shakes in rats.
    Keshavan HJ; Gurbani NK; Dandiya PC
    Psychopharmacology (Berl); 1980; 70(2):209-12. PubMed ID: 6159662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of developing rats to L-tryptophan plus an MAOI-I. Monitoring changes in behaviour, brain 5-HT and tryptophan.
    Atterwill CK; Green AR
    Neuropharmacology; 1980 Apr; 19(4):325-35. PubMed ID: 7383278
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic systems in brain and blood under stress and tranylcypromine treatment in rats.
    Malyszko J; Urano T; Takada Y; Takada A
    Brain Res Bull; 1994; 35(1):9-13. PubMed ID: 7525025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.
    Costain DW; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):193-200. PubMed ID: 30503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.
    Sleight AJ; Marsden CA; Martin KF; Palfreyman MG
    Br J Pharmacol; 1988 Feb; 93(2):303-10. PubMed ID: 2451963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective effect of tranylcypromine enantiomers on brain serotonin.
    Smith DF; Petersen HN
    Life Sci; 1982 Nov; 31(22):2449-54. PubMed ID: 6185814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs.
    Evans JP; Grahame-Smith DG; Green AR; Tordoff AF
    Br J Pharmacol; 1976 Feb; 56(2):193-9. PubMed ID: 3248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some observations on the behavioural and biochemical effects of L-tryptophan plus a monoamine oxidase inhibitor in immature rats [proceedings].
    Atterwill CK; Costain DW; Green AR
    Br J Pharmacol; 1979 May; 66(1):118P-119P. PubMed ID: 454914
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of the specific uptake inhibitor Lu 10-171 (citalopram) upon brain indoleamine stores in the maturing mouse.
    Baker PC; Goodrich CA
    Gen Pharmacol; 1982; 13(1):59-61. PubMed ID: 6174394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic measures in blood and brain and their correlations in rats treated with tranylcypromine, a monoamine oxidase inhibitor.
    Malyszko J; Urano T; Serizawa K; Yan D; Kozima Y; Takada Y; Takada A
    Jpn J Physiol; 1993; 43(5):613-26. PubMed ID: 7511710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro.
    Hyttel J
    Psychopharmacology (Berl); 1978 Dec; 60(1):13-8. PubMed ID: 104340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a selective 5-HT uptake inhibitor--Lu 10-171--on rat brain 5-HT turnover.
    Hyttel J
    Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):439-46. PubMed ID: 139078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of butaclamol, a new neuroleptic, on serotoninergic mechanisms.
    Pugsley TA; Lippmann W
    J Pharm Pharmacol; 1977 Mar; 29(3):135-8. PubMed ID: 15075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tryptamine in the behavioural effects of tranylcypromine + L-tryptophan.
    Marsden CA; Curzon G
    Neuropharmacology; 1979 Feb; 18(2):159-64. PubMed ID: 431783
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of tranylcypromine on 5-HT uptake and its interaction with PCPA on rat brain 5-HT.
    Friedman E; Shopsin B; Gershon S
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):191-4. PubMed ID: 135325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.